Claudia Silva
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Niacin Modulates Immune Responses in a Phase I Dose-Escalation Clinical Trial of Newly Diagnosed Glioblastoma.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 03, 2026
Targeted deletion of EMMPRIN in microglia/macrophages mitigates neuronal death in intracerebral hemorrhage.
Journal: Molecular neurodegeneration
Published: June 13, 2025
Fibulin-2 is an extracellular matrix inhibitor of oligodendrocytes relevant to multiple sclerosis.
Journal: The Journal of clinical investigation
Published: October 23, 2023
Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 18, 2022
Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis.
Journal: European journal of neurology
Published: May 11, 2022
Exercise rapidly alters proteomes in mice following spinal cord demyelination.
Journal: Scientific reports
Published: September 08, 2020
Multimodal peripheral fluid biomarker analysis in clinically isolated syndrome and early multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: August 19, 2020
The glycosyltransferase EXTL2 promotes proteoglycan deposition and injurious neuroinflammation following demyelination.
Journal: Journal of neuroinflammation
Published: April 05, 2020
Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 19, 2019
Targeting the Chondroitin Sulfate Proteoglycans: Evaluating Fluorinated Glucosamines and Xylosides in Screens Pertinent to Multiple Sclerosis.
Journal: ACS central science
Published: March 30, 2019
Last Updated: 09/26/2026